Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Not applicableStudy completedNCT00828516What this trial is testingUsing Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaWho this might be right forBreast CancerHead and Neck CancerLymphedema East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01220752What this trial is testingTreatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)Who this might be right forSinonasal MalignanciesAdenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses Heidelberg University 36
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT03274414What this trial is testingA Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal PassagesWho this might be right forParanasal Sinus CancerNasal Cavity TumorNasal Cavity Adenocarcinoma Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT00544336What this trial is testingFamily Quality of Life Among Families With a Member Who is a Cancer PatientWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+3 more Vanderbilt-Ingram Cancer Center 366
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00005647What this trial is testingSU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT00098943What this trial is testingNGR-TNF in Treating Patients With Advanced Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerKidney Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC 70
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00897793What this trial is testingGrowth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+2 more Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Early research (Phase 1)WithdrawnNCT00937417What this trial is testingS0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more SWOG Cancer Research Network